Seattle Genetics
TIVDAK
Manufacturer:
Seattle Genetics
Name:
TIVDAK
HCPCS Code Descriptor:
Injection, tisotumab vedotin-tftv, 1 mg
Category:
J Code
HCPCS:
J9273
NDC(s):
51144-0003-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
TIVDAK is an Oncology drug manufactured by Seattle Genetics and administered via the Intravenous route of administration. The J Code: J9273 is aligned to the drug TIVDAK.
Access Pricing and More By Registering
HCPCS Added Date:
4/1/22
HCPCS Effective Date:
4/1/22
HCPCS Short Description:
Inj tisotu vedotin-tftv, 1mg
Billing and Coding Guide:
https://www.seagensecure.com/assets/pdfs/Tivdak/TIVDAK-Billing-and-Coding-Guide.pdf
Patient Assistance:
https://www.seagensecure.com/patient/tivdak